NEW YORK, March 26 –Applied Biosystems said last week that a drop in demand for its ABI Prism 3700 DNA Analyzers reflected genomics companies’ efforts to rein in spending while they ride out the economic downturn.

But conversations with a number of executives at development-stage genomics companies and consulting firms indicated that spending plans have not changed due to present market conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.